The therapy with nasal insufflation (TNI®) was developed for both clinical intensive and inpatient care as well as for home care use. Patients show a high tolerance for this therapy and it is even suitable in cases where conventional respiratory masks are not tolerated very well.THI® (Therapy with Nasal Insufflation) has been known in clinical everyday life though it is still a new respiratory support method. It is a nasal high-flow ventilation method.
In therapy with nasal insufflation, a constant, warm and humidified airstream is conducted into the patient’s nose via a thin nasal cannula (applicator); if required, oxygen can be added to the stream. This generally leads to improved ventilation. Therapy with nasal insufflation shows a high tolerance with excellent success.
Plenty of evidence and clinical findings exist that prove that nasal therapy insufflation.
The presented findings support therapy with nasal insufflation in particular as an alternative option to NIV therapy for further reducing mechanical respiratory support or for patients who do not tolerate a conventional respiratory mask.
The therapy is applied successfully in clinical intensive and inpatient care as well as in home care.